Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kai Siang Chan, Wei Xuan Tay, Feng Yi Cheo & Vishal G. Shelat. (2023) Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis. Acta Chirurgica Belgica 123:6, pages 601-617.
Read now
Read now
Shizheng Mi, Yang Nie & Changming Xie. (2022) Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology 57:9, pages 1070-1079.
Read now
Read now
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan & Jian Shui Li. (2019) Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 54:2, pages 240-245.
Read now
Read now
Articles from other publishers (19)
Fabio Giannone, Emanuele Felli, Federica Cipriani, Bruno Branciforte, Rami Rhaiem, Bader Al Taweel, Raffaele Brustia, Ephrem Salame, Fabrizio Panaro, Daniele Sommacale, Tullio Piardi, Guido Torzilli, Luca Aldrighetti, Catherine Schuster & Patrick Pessaux. (2024) Prognostic benefit of preoperative transarterial chemoembolization in upfront resectable large hepatocellular carcinoma: a multicentric propensity score based analysis of European high-volume centers. HPB.
Crossref
Crossref
Pipit Burasakarn, Sermsak Hongjinda, Anuparp Thienhiran, Nichaphat Phancharoenkit & Pusit Fuengfoo. (2023) Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study. International Journal of Gastrointestinal Intervention 12:4, pages 169-175.
Crossref
Crossref
Ali Mo, Qiao Zhang, Feng Xia, Zhiyuan Huang, Shasha Peng, Wenjing Cao, Hongliang Mei, Li Ren, Yang Su, Hengyi Gao & Weiqiang Chen. (2022) Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study. Cancer Medicine 12:7, pages 7734-7747.
Crossref
Crossref
Luke Zhou, Mao Zhang & Siyu Chen. (2023) Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis. Annals of Hepatology 28:2, pages 100890.
Crossref
Crossref
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou & Xie Hui. (2023) Current status and prospect of treatments for recurrent hepatocellular carcinoma. World Journal of Hepatology 15:2, pages 129-150.
Crossref
Crossref
Qiao Zhang, Feng Xia, Ali Mo, Weiming He, Jiazhen Chen, Weiqiao Zhang & Weiqiang Chen. (2022) Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical Study. Frontiers in Oncology 12.
Crossref
Crossref
Hai-Tao Zhao & Jian-Qiang Cai. (2021) Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World Journal of Gastroenterology 27:47, pages 8069-8080.
Crossref
Crossref
Zhan-Qi Wei & Yue-Wei Zhang. (2021) Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit. Chinese Medical Journal 134:19, pages 2275-2286.
Crossref
Crossref
Jun-Cheng Wang, Jing-Yu Hou, Jian-Cong Chen, Cai-Ling Xiang, Xian-Hai Mao, Bing Yang, Qiang Li, Qing-Bo Liu, Jinbin Chen, Zhi-Wei Ye, Wei Peng, Xu-Qi Sun, Min-Shan Chen, Qun-Fang Zhou & Yao-Jun Zhang. (2021) Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection. European Journal of Cancer 155, pages 85-96.
Crossref
Crossref
Maria Tampaki, George Vasileios Papatheodoridis & Evangelos Cholongitas. (2021) Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 14:3, pages 699-713.
Crossref
Crossref
Ligia Craciun, Roland de Wind, Pieter Demetter, Valerio Lucidi, Ali Bohlok, Sébastien Michiels, Fikri Bouazza, Michael Vouche, Ilario Tancredi, Gontran Verset, Soizic Garaud, Céline Naveaux, Maria Gomez Galdon, Karen Willard Gallo, Alain Hendlisz, Ivan Duran Derijckere, Patrick Flamen, Denis Larsimont & Vincent Donckier. (2020) Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy. BMC Cancer 20:1.
Crossref
Crossref
Chao Li, Ming-Da Wang, Lun Lu, Han Wu, Jiong-Jie Yu, Wan-Guang Zhang, Timothy M. Pawlik, Yao-Ming Zhang, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Jun Han, Hao Xing, Zhen-Li Li, Wan Yee Lau, Meng-Chao Wu, Feng Shen & Tian Yang. (2019) Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis. Hepatology International 13:6, pages 736-747.
Crossref
Crossref
Liming Wang, Li Feng, Weiqi Rong, Mei Liu, Fan Wu, Weibo Yu, Songlin An, Xiang Zhou & Jianxiong Wu. (2019) Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways. Journal of Gastrointestinal Surgery 23:9, pages 1767-1777.
Crossref
Crossref
Mégane Lemaire, Valerio Lucidi, Fikri Bouazza, Georgios Katsanos, Bruno Vanderlinden, Hugo Levillain, Philippe Delatte, Camilo A. Garcia, Michael Vouche, Maria Gomez Galdon, Pieter Demetter, Amélie Deleporte, Alain Hendlisz, Patrick Flamen & Vincent Donckier. (2018) Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study. HPB 20:7, pages 641-648.
Crossref
Crossref
Franco Orsi. 2018. Locoregional Tumor Therapy. Locoregional Tumor Therapy
43
82
.
Michael Vouche, Thierry Degrez, Fikri Bouazza, Philippe Delatte, Maria Gomez Galdon, Alain Hendlisz, Patrick Flamen & Vincent Donckier. (2017) Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma. World Journal of Hepatology 9:36, pages 1372-1377.
Crossref
Crossref
Maryam Salari, Anoshirvan Kazemnejad & Farid Zayeri. (2017) Clustering Asian Countries According to the Trend of liver cancer Mortality Rates: an Application of Growth Mixture Models. Iranian Red Crescent Medical Journal 19:8.
Crossref
Crossref
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Ruoyu Guan, Boyong Shen & Chenghong Peng. (2017) Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta‐analysis. Journal of Gastroenterology and Hepatology 32:7, pages 1286-1294.
Crossref
Crossref
Jun-Cheng Wang, Jing-Yu Hou, Jian-Cong Chen, Cai-Ling Xiang, Xian-Hai Mao, Bing Yang, Qiang Li, Qing-Bo Liu, Jinbin Chen, Zhi-Wei Ye, Wei Peng, Minshan Chen, Qun-Fang Zhou & Yao-Jun Zhang. (2020) Development and Validation of Prognostic Nomograms for BCLC A Stage Hepatocellular Carcinoma Beyond Milan Criteria after Curative Resection. SSRN Electronic Journal.
Crossref
Crossref